The U.S. Food and Drug Administration (FDA) is planning to authorize booster doses of Pfizer-BioNTech’s COVID-19 vaccine for all adults as early as Thursday, according to a report from The New York Times.
This means that all fully vaccinated adults aged 18 and older will be able to receive the extra dose six months after their final dose.
An advisory committee to the Centers for Disease Control and Prevention (CDC) is planning to meet on Friday to discuss data on the booster shot.
Read more of the original article from DailyMail
